Literature DB >> 3140224

Calcium channel antagonists delay regression of androgen-dependent tissues and suppress gene activity associated with cell death.

J Connor1, I S Sawczuk, M C Benson, P Tomashefsky, K M O'Toole, C A Olsson, R Buttyan.   

Abstract

Androgen deprivation subsequent to castration of an adult male rat results in the regression of sexual accessory tissues. Regression of these tissues involves the massive death of androgen-dependent cells. Using the rat ventral prostate gland as a model to study androgen-programed cell death, we have characterized a series of molecular events that accompany its regression. This analysis has shown that there was a sequential induction of specific gene transcripts in the ventral prostate gland following castration. The first event in this cascade was an abrupt induction of transcripts encoding c-fos. Since c-fos expression has been linked to perturbations in intracellular Ca2+ levels, we investigated whether membrane-mediated Ca2+ flux might be an early physiological step involved in the death of prostatic cells. To test this, rats were treated simultaneously upon castration with either verapamil or nifedipine, two different calcium channel antagonist drugs. Compared to the ventral prostate glands of untreated castrated rats, the glands of the calcium channel antagonist-treated rats showed a significant delay in all parameters associated with regression (loss of wet weight and DNA content and delay in histological changes associated with prostatic regression). The seminal vesicle glands of treated rats also showed signs of delayed regression. Furthermore, calcium channel antagonists suppressed the induction of transcripts encoding both c-fos and testosterone-repressed prostate message-2 (TRPM-2), a gene expressed exclusively by dying cells, during the first 62 hr following castration. These findings further support a role for calcium ion influx in the pathway leading to hormonally programed prostate cell death, and suggest the intriguing possibility that modulation of this activity can alter the process by which cells die.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3140224     DOI: 10.1002/pros.2990130204

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  16 in total

Review 1.  Active cell death in hormone-dependent tissues.

Authors:  M P Tenniswood; R S Guenette; J Lakins; M Mooibroek; P Wong; J E Welsh
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

Review 2.  Penile shortening after radical prostatectomy and Peyronie's surgery.

Authors:  Jonas S Benson; Michael R Abern; Laurence A Levine
Journal:  Curr Urol Rep       Date:  2009-11       Impact factor: 3.092

Review 3.  Is the use of some calcium antagonists linked to cancer? Evidence from recent observational studies.

Authors:  M Pahor; C D Furberg
Journal:  Drugs Aging       Date:  1998-08       Impact factor: 3.923

Review 4.  Calcium antagonists and cancer. Is there really a link?

Authors:  L G Howes; C T Edwards
Journal:  Drug Saf       Date:  1998-01       Impact factor: 5.606

5.  Genes regulated by androgen in the rat ventral prostate.

Authors:  Z Wang; R Tufts; R Haleem; X Cai
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

6.  Expression and function of the leucine zipper protein Par-4 in apoptosis.

Authors:  S F Sells; S S Han; S Muthukkumar; N Maddiwar; R Johnstone; E Boghaert; D Gillis; G Liu; P Nair; S Monnig; P Collini; M P Mattson; V P Sukhatme; S G Zimmer; D P Wood; J W McRoberts; Y Shi; V M Rangnekar
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

7.  Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation.

Authors:  R R Berges; Y Furuya; L Remington; H F English; T Jacks; J T Isaacs
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

8.  Induction of the TRPM-2 gene in cells undergoing programmed death.

Authors:  R Buttyan; C A Olsson; J Pintar; C Chang; M Bandyk; P Y Ng; I S Sawczuk
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

9.  Cardiovascular medication use and risk for colorectal cancer.

Authors:  Denise M Boudreau; Elizabeth Koehler; Stephen J Rulyak; Sebastien Haneuse; Robert Harrison; Margaret T Mandelson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10-28       Impact factor: 4.254

10.  A Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive Phenotype.

Authors:  Guangjing Zhu; Zhi Liu; Jonathan I Epstein; Christine Davis; Christhunesa S Christudass; H Ballentine Carter; Patricia Landis; Hui Zhang; Joon-Yong Chung; Stephen M Hewitt; M Craig Miller; Robert W Veltri
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-09-24       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.